Terminology Service < Semantic Lookup Platform

All terms in GO

Label	Id	Description
positive regulation of ERBB signaling pathway	GO_1901186	[Any process that activates or increases the frequency, rate or extent of ERBB signaling pathway.]
regulation of cardiac cell fate specification	GO_2000043	[Any process that modulates the frequency, rate or extent of cardiac cell fate specification.]
cardiac cell fate specification	GO_0060912	[The process involved in the specification of cardiac cell identity. Once specification has taken place, a cell will be committed to differentiate down a specific pathway if left in its normal environment.]
negative regulation of planar cell polarity pathway involved in axis elongation	GO_2000041	[Any process that stops, prevents, or reduces the frequency, rate or extent of planar cell polarity pathway involved in axis elongation.]
negative regulation of non-canonical Wnt signaling pathway	GO_2000051	[Any process that stops, prevents, or reduces the frequency, rate or extent of non-canonical Wnt signaling pathway.]
regulation of planar cell polarity pathway involved in axis elongation	GO_2000040	[Any process that modulates the frequency, rate or extent of planar cell polarity pathway involved in axis elongation.]
planar cell polarity pathway involved in axis elongation	GO_0003402	[The series of molecular signals initiated by binding of a Wnt protein to a receptor on the surface of the target cell where activated receptors signal to modulate cytoskeletal elements and control cell polarity that contributes to axis elongation.]
negative regulation of double-strand break repair via homologous recombination	GO_2000042	[Any process that stops, prevents, or reduces the frequency, rate or extent of double-strand break repair via homologous recombination.]
negative regulation of DNA recombination	GO_0045910	[Any process that stops, prevents, or reduces the frequency, rate or extent of DNA recombination.]
regulation of cell-cell adhesion mediated by cadherin	GO_2000047	[Any process that modulates the frequency, rate or extent of cell-cell adhesion mediated by cadherin.]
negative regulation of cell-cell adhesion mediated by cadherin	GO_2000048	[Any process that stops, prevents, or reduces the frequency, rate or extent of cell-cell adhesion mediated by cadherin.]
regulation of G1/S transition of mitotic cell cycle	GO_2000045	[Any signalling pathway that modulates the activity of a cell cycle cyclin-dependent protein kinase to modulate the switch from G1 phase to S phase of the mitotic cell cycle.]
regulation of cell cycle G1/S phase transition	GO_1902806	[Any signalling pathway that modulates the activity of a cell cycle cyclin-dependent protein kinase to modulate the switch from G1 phase to S phase of the cell cycle.]
G1/S transition of mitotic cell cycle	GO_0000082	[The mitotic cell cycle transition by which a cell in G1 commits to S phase. The process begins with the build up of G1 cyclin-dependent kinase (G1 CDK), resulting in the activation of transcription of G1 cyclins. The process ends with the positive feedback of the G1 cyclins on the G1 CDK which commits the cell to S phase, in which DNA replication is initiated.]
obsolete regulation of G2 phase of mitotic cell cycle	GO_2000046	[OBSOLETE. Any process that modulates the frequency, rate or extent of G2 phase of mitotic cell cycle.]
response to 5-fluoro-2'-deoxyuridine	GO_0097330	[Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a 5-fluoro-2'-deoxyuridine stimulus. 5-fluoro-2'-deoxyuridine is a pyrimidine 2'-deoxyribonucleoside compound having 5-fluorouracil as the nucleobase; it is used to treat hepatic metastases of gastrointestinal adenocarcinomas and for palliation in malignant neoplasms of the liver and gastrointestinal tract.]
response to antimetabolite	GO_0097329	[Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an antimetabolite stimulus. An antimetabolite is a substance which is structurally similar to a metabolite but which competes with it or replaces it, and so prevents or reduces its normal utilization.]
response to cytarabine	GO_0097331	[Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cytarabine stimulus.]
response to glycoside	GO_1903416	[Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a glycoside stimulus.]
response to antipsychotic drug	GO_0097332	[Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an antipsychotic drug stimulus. Antipsychotic drugs are agents that control agitated psychotic behaviour, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect.]